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Introduction: High serum levels of estradiol are associated with clinical evidence of varicose veins in women; however, the
relationship between serum sex steroid hormones and varicose veins in men is unclear. To address this issue, serum levels
of testosterone, estradiol, and androstenedione were determined in the great saphenous (GSV) and cubital veins of men
with varicose veins. Messenger RNA (mRNA) expression of sex steroid hormones, metabolizing enzymes, and their
receptors was investigated in tissue samples of leg veins.
Methods: This prospective study included 40 men, comprising 20 with varicose veins and reflux of the GSV (VM) and 20
with healthy veins (HM). All limbs were assessed by duplex ultrasound scanning of selected superficial and deep leg veins.
Blood samples were taken from the cubital vein and from the GSV. Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR) analysis for sex steroid hormones, their metabolizing enzymes, and receptors in saphenous veins was
performed in tissue samples of varicose (n  6) and healthy veins (n  6).
Results: The VM group had significantly higher (P < .001) mean levels for serum testosterone (44.9 nmol/L; range,
8.8-225.1) and estradiol (242.2 pmol/L; range, 79-941) in varicose saphenous veins compared with cubital veins (testoster-
one, 15.5 nmol/L; range, 8.4-23.3; estradiol, 93.2 pmol/L; range, 31-147). Moreover, significantly (P< .001) higher mean
serum estradiol levels (133.2 pmol/L; range, 63-239) were detected in the saphenous veins of the HM group compared with
cubital veins (88.15 pmol/L; range, 37-153). Both groups had similar blood counts and serum androstenedione levels in the
upper and lower extremity. Interestingly, qRT-PCR revealed that the mRNA expression of 5-reductase type 1, 5-reductase
type 2, 17, 20 lyase, 17-hydroxysteroid dehydrogenase (17-HSD), aromatase and 3-HSD type 2, androgen and estrogen
receptor 1 was down-regulated (P < .05) in all samples of varicose veins vs veins obtained from healthy men.
Conclusion: Elevated serum estradiol and testosterone levels were detected in men with varicose veins and reflux in the GSV
compared with the patient’s own arm veins. Enzymes and hormonal receptors involved in steroid metabolism were
down-regulated in patients with GSV reflux and varicose veins, suggestive of a negative feedback regulation. These data
support the notion of a possible causal relationship between sex steroids and varicose veins in men. (J Vasc Surg 2010;51:
639-47.)Primary varicose veins are a common disease of the
lower extremity.1 It affects about 10% to 40% of 30- to
70-year-old individuals in industrialized countries.2 Every
sixth man and every fifth woman have chronic venous
insufficiency.3,4 In some patients with varicose veins, seri-
ous complications will develop, such as superficial vein
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Chronic venous disease is also associated with a reduced
quality of life. Predisposing factors such as familial trans-
mission, age, obesity, and prolonged standing could have
an effect in the development of varicosity.5,6
Although sex steroid hormones are known to influence
endothelial cell function and blood viscosity, their influence
and that of their receptors in the pathogenesis of varicose
disease are not fully understood. In women, an association
between pregnancies and high serum levels of estradiol
with the clinical manifestation of varicose veins has been
suggested. No association was found for sex hormone-
binding globulin or testosterone.7,8
Several lines of evidence also support a role for sex
steroid hormones in the pathogenesis of varicose veins in
men. An elevated serum estradiol/testosterone ratio was
found in men with primary varicose veins compared with
healthy controls.9 Howell et al10 reported that men with
chronic venous disease are more adipose, less fertile, and
have an increased body height.
In patients with pelvic congestion syndrome, estrogen
levels in the leg were higher than that in the arm in the
presence of reflux.11 This may point to a possible role of
locally elevated estrogen levels in the varicose leg with
reflux compared with the healthy arm. However, the situ-
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in men with reflux of great saphenous veins (GSVs) and in
men without reflux is unclear. Therefore, we tested the
hypothesis that serum testosterone and estradiol levels may
be different in the leg with GSV reflux and in the healthy
arm as well as in leg veins of men without reflux of GSV
compared with the arm veins. For this purpose, serum and
blood count measurements from GSV (with and without
reflux) and brachial veins were performed. In addition, we
investigated messenger RNA (mRNA) levels of sex steroid
hormones, their metabolizing enzymes, and receptors in sa-
phenous vein samples by quantitative reverse-transcription
polymerase chain reaction (qRT-PCR).
MATERIALS AND METHODS
The study protocol was approved by the Ethics Com-
mittee of the University of Leipzig (AZ 049-2008). All
patients provided written informed consent before under-
going any study-related procedure. The clinical study was
performed as an open, prospective, single-center study at
theDepartment of Dermatology, Venerology and Allergol-
ogy at Leipzig University Medical Center, Leipzig, Ger-
many. Surplus segments of healthy saphenous veins isolated
for coronary artery bypass grafting were provided by the
Department of Cardiac Surgery.
Study population. From January 2008 to September
2008, patients who were referred to our institution for
surgical treatment of varicose veins, for skin changes, or
healthy volunteers, were considered for inclusion. Of the
45 patients approached, 20 participated. We contacted 29
individuals for the control group, and 20 participated. A
total of 40men, comprising 20menwith reflux500ms of
the GSV (VM) and 20 men with a competent GSV (HM)
were included. Inclusion and exclusion criteria are detailed
in Table I.
A standard set of clinical information was collected,
including age, weight, height, family history of chronic
venous disease, short medical history, and systemic medi-
cation intake. We used standard equipment to measure
height (m) and weight (kg) and calculated body mass index
(BMI) as kg/m2.
All limbs were assessed for the presence of varicose
veins and complete CEAP classification was performed.
Duplex ultrasound scanning with transducer frequencies
between 5 and 7.5 MHz (Titan, SonoSite, Bothell, Wash),
including measuring characteristics of outflow and reflux
for the lower limb, was performed by the same experienced
investigator in all patients. Venous flow was examined in
longitudinal sections using color flow, and pulsed Doppler
ultrasound imaging was used for measuring the reverse
flow. Femoral, midthigh femoral, above-knee popliteal,
and distal posterior tibial veins were examined for deep
venous reflux. The GSV and the small saphenous vein were
imaged continuously from the respective femoral or popli-
teal junction to the paramalleolar level. Reflux was defined
as reverse flow 0.5 seconds in the superficial veins or 1.0
second in the deep veins after a manual compression-release
maneuver. The examination was performed with the pa-tient standing.12 All patients with symptomatic varicose
veins underwent surgical or endoluminal therapy.
Venous sample collection. Samples were obtained
from six patients (age range, 55.8 5.9 years; BMI, 28.2
4.9 kg/m2) undergoing surgical removal of varicose saphe-
nous veins. Healthy segments of saphenous veins (control)
were isolated from six men (age range, 64.0  4.9 years;
BMI, 28.5  3.2 kg/m2) undergoing coronary artery
bypass grafting. The control group did not undergo duplex
ultrasound scanning of the GSV before surgery. The GSV
was harvested below the knee at a location from 5 to 15 cm
in all cases. All veins were immediately cryopreserved in
Jung tissue freezing medium (Leica Microsystems Nuss-
loch GmbH, Nussloch, Germany) at –80°C until analysis
was performed.
Serum and blood count measurements. Nonfasting
blood samples were obtained in 5-mL Vacutainer tubes
(BD Diagnostics, Franklin Lakes, NJ) from the antecubital
vein or by ultrasound-guided puncture of a part of the GSV
of the lower extremity with the individual sitting. All blood
samples were obtained in the morning between 8:00 AM
and 12:00 PM. The samples were stored for a maximum of 8
hours at 2° to 8°C before centrifugation and separation of
serum. Serum was stored at 20°C.
Levels of testosterone and estradiol were determined by
the Elecsys 2010 fully automated immunoassay system
(Roche, Basel, Switzerland). Levels of androstenedione
were measured by an immunoradiometric assay from DSL
(Sinsheim, Germany). All other blood parameters were
determined by the Modular Analyzer (Roche).
RNA preparation and complimentary DNA synthesis.
Total RNA from the venous tissue was prepared using
Table I. Selection criteria
Criteria Men with varicose veins Healthy men
Inclusion Symptomatic varicose veins No symptomatic
veins
CEAP C 2 CEAP C 1
DUS with reflux in
superficial veins 0.5 sec
DUS with reflux in
superficial veins
0.5 sec
Reflux in the deep veins, 
1.0 sec
Reflux in the deep
veins,  1.0 sec
Inpatient for vein surgery
or endoluminal
treatment
Age: 20-80 years Age: 20-80 years
Informed consent Informed consent
Short medical history Short medical history
Blood withdrawal (arm/
leg)
Blood withdrawal
(arm/leg)
Exclusion Hormone intake Hormone intake
Cancer Cancer
Elevated liver enzymes Elevated liver
enzymes
Superficial
thrombophlebitis
Varicose veins
DUS, Duplex ultrasound imaging.TRIZOL (Invitrogen, Germany). Briefly, the tissue (about
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homogenized twice using an Ultra-Turrax (IKA, Nesher,
Israel) homogenizer for 20 seconds each. After separation
of organic and anorganic phases, the RNA was precipitated
from the aqueous phase by the addition of isopropanol, as
suggested by the manufacturer. The quantity and quality of
the obtained RNA was determined by spectrophotometry
(ND-1000, NanoDrop Technologies Inc, Wilmington,
Del). Total RNA (1 g) from each sample was used for
first-strand complimentary DNA (cDNA) synthesis using
M-MLV Reverse Transcriptase and Oligo(dT) (Promega,
Madison, Wis), following the manufacturer’s instructions.
Quantitative RT-PCR analysis. Analysis of gene ex-
pression of sex steroid hormones, their metabolizing en-
zymes, and receptors was done using the SYBRGreen PCR
Master Mix (Applied Biosystems, Darmstadt, Germany)
according to the manufacturer’s instructions. The primers
used were designed using Primer Express 2.0 software
(Applied Biosystems, Table II). The reaction mixtures were
amplified for 40 cycles at an annealing temperature of 55°C
using an ABI PRISM 7000 instrument (Applied Biosys-
tems). The assessed data were evaluated using the Sequence
Detection 1.2.3 software (Applied Biosystems). Ribosomal
protein S26 was used as an endogenous control for the
relative quantification of the target messages. The primer
concentration optimization and the absence of nonspecific
products were confirmed by performing dissociation curve
analysis, which resulted in single products at specific melt-
ing temperatures.
Statistical analysis. Results were analyzed using de-
scriptive statistics and are presented as mean  standard
Table II. Primer sequences
Gene name Enzyme
17, 20 LYASE 17, 20 lyase
3-HSD-2 3-Hydroxysteroid dehydrogenase type 2
5AR1 5	-reductase type 1
5AR2 5	-reductase type 2
17-HSD 17-Hydroxysteroid dehydrogenase
AROMATASE Aromatase
ESR-1 Estrogen receptor 1
ESR-2 Estrogen receptor 2
AR Androgen receptor
GHR Growth hormone receptor
HKG-RSP Ribosomal protein S26
HKG, Housekeeping gene.deviation. Correlation analysis (Spearman rank correlationcoefficient and a test of   0) was performed to determine
whether height or weight affected the concentrations of
serum sex steroid hormones or blood count. Nonparamet-
ric statistics (median and quartiles; Wilcoxon-Mann-Whitney)
were used. Statistical significance for the RT-PCR results
was calculated by the two-sample independent-groups t
test. The statistical significance was defined by values of P
.05. All calculations were performed using the SPSS 11.5
software (SPSS Inc, Chicago, Ill) and Statistica 7.1 software
(Statsoft Software, Tulsa, Okla).
RESULTS
Patient demographics, clinical parameters, laboratory
data parameters, and “C” of CEAP classification are re-
ported in Table III and in part in Fig 1. Further supporting
the findings of the study is that the VM group was signifi-
cantly older than the HM group.
In brief, themean serum levels of estradiol in theVM-arm
and VM-leg groups demonstrated a significant difference
(arm/leg difference, P  .001, Table III, Fig 1, 1a). Also in
the HM group, estradiol levels in the legs and arms were
significantly different (arm/leg difference, P  .001; Table
III, Fig 1, 2a). A similar observation for the estradiol level was
made for the C0 subgroup (n 12; arm/leg difference, P
.002) and C1 subgroup (n  8; arm/leg difference, P 
.012). Moreover, mean of testosterone levels in the VM-arm
and in the VM-leg groups displayed a significant difference
(arm/leg difference, P .001; Table III, Fig 1, 1b), whereas
no differences could be demonstrated in HM (Table III, Fig
1, 2b). Interestingly, the mean serum levels of estradiol and
testosterone in theVM-leg andHM-leg groups demonstrated
Primer sequence
Product
size (bp)
Temp
(°C)
CGATCAGAAGCTGGAGAAGAT 106 79
: CACGAAGACAGGAAAGGAGAT
GGACCAAGCTGACTGTACTTG 135 80
: TGATGGACTCTCTGTGAGTGAC
TCATGGAGTGGTGTGGCTA 121 80
: TTCCGGAGGTACCACTCAT
ATTCTCAGAGGCACTGCCT 121 79
: AGAAGACACCCAAGCTAAACC
GGCTTGTTTGAGGTTGGAG 149 79
: GCTGGCATTCTCAAAGTCAC
GGACTTTGCCACTGAGTTGA 111 79
: ACAGACATGGTGTCAGGAGCT
ATCATCTCGGTTCCGCAT 129 78
: TGGTCCTTCTCTTCCAGAGACT
TCGTGTGAAGGATGTAAGGC 144 77
: CACTTCGTAACACTTCCGAAGT
TTCTACCAGCTCACCAAGCT 146 81
: GGCACTTGCACAGAGATGAT
TCACCAAGCTGCCCATAT 175 80
: TGGCAGAGTGAGACCATTTC
GCAGCAGTCAGGGACATTTCTG 68 79
: TTCACATACAGCTTGGGAAGCAF:
R
F:
R
F:
R
F:
R
F:
R
F:
R
F:
R
F:
R
F:
R
F:
R
F:
Ra significant difference (estradiol, P .021; testosterone, P
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arm and leg levels of androstenedione, hemoglobin, leuco-
cytes, andplateletswere investigated inVMorHM(Table III,
Fig 1, 1c).
To address a possible confounding of the association
between serum sex steroid hormones or blood count by
height or weight and age, these parameters were analyzed.
In the VM group, there was no significant association
between age and serum sex steroid hormones or blood
count. In the HM group, a significant negative correlation
was found between estradiol arm and age (r  –0.666),
estradiol leg and age (r  –0.667), androstenedione arm
Table III. Baseline characteristics of men with varicose ve
Variable
General characteristics
Age, y
Body mass index, kg/m2
Serum sex hormone levels and blood count
Estradiol, pmol/L (40-161)a
Arm
Leg
Testosterone, nmol/L (9.9-27.8)a
Arm
Leg
Androstenedione, nmol/L (1.04-10.7)a
Arm
Leg
Hemoglobin, nmol/L (7.8-10.8)a
Arm
Leg
Leucocytes, 109/L (4.0-9.0)a
Arm
Leg
Platelets, 109/L (150-300)a
Arm
Leg
Comorbidities
Hypertension
Allergy
Psoriasis
Hypercholesterolemia
COPD
Current smoking
Medication
Antihypertensive drugs
NSAIDs
Sympathomimetic
Allopurinol
TNF inhibitor
CEAP C
C0
C1
C2
C3
C4
C5
C6
COPD, Chronic obstructive pulmonary disease; HM, healthy men; NSAID
aNormal reference range.
bMedian value.and age (r  –0.762), androstenedione leg and age (r –0.620), hemoglobin arm and age (r  –0.662), and
hemoglobin leg and age (r  –0.679). In contrast, a
significant positive correlation in the VM group was found
between hemoglobin arm and weight (r  0.443), hemo-
globin leg and weight (r  0.510), leucocytes leg and
weight (r  0.446), leucocytes arm and height (r 
0.382), and platelets leg and height (r  0.401). A
significant negative correlation was found between estra-
diol arm and height (r  –0.643). Finally, a positive
correlation between estradiol arm and height (r 
0.634) and estradiol leg and height (r  0.508) was
observed in the HM group. A negative correlation ex-
nd healthy men
VM (n  20) HM (n  20)
ean  SD or No. Mean  SD or No.
 10.8 45.7  16.9
 3.2 25.2  3.0
 28.5 (93.0)b 88.2  32.7 (99.0)b
 208.6 (189.5)b 133.2  42.9 (125.5)b
 5.0 (16.3)b 16.1  6.0 (15.0)b
 61.1 (25.0)b 18.0  10.0 (14.6)b
 1.9 4.6  1.7
 5.0 4.8  1.8
 0.6 9.2  0.5
 0.7 9.2  0.6
 1.4 6.5  1.7
 1.4 6.5  1.8
 1.4 237.4  40.9
 47.2 238.5  44.2
8 5
1 1
0 1
1 0
1 0
6 4
8 5
2 3
1 0
1 0
0 1
0 12
0 8
2 0
9 0
7 0
1 0
1 0
steroidal anti-inflammatory drugs; VM, varicose veins.ins a
M
57.3
27.0
93.2
242.2
15.5
44.9
5.1
7.3
9.3
9.4
6.0
6.1
243.2
246.8
s, nonisted between testosterone arm and weight (r 
e wh
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hemoglobin leg and height (r  –0.568).
Quantitative RT-PCR analysis revealed that the gene
Fig 1. Serumlevelof (a)estradiol, (b) testosterone, and (c)a
and (2) healthymen (HM).3, Serum level of estradiol and tes
the quartiles, the horizontal line designates the median, and thexpression of 17, 20 lyase, 5	-reductase type 1, 5	-reductasetype 2, 17-hydroxysteroid dehydrogenase (HSD), aro-
matase, and 3-HSD type 2 was significantly down-
regulated in varicose vein samples from patients com-
tenedione in thearm/legof (1)menwithvaricoseveins (VM)
one in legs of VMandHM.The edge of each box represents
iskers represent the extreme values (outliners not shown).ndros
tosterpared with controls (Fig 2, a-f). Further, the gene ex-
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was significantly down-regulated in patients’ samples
compared with controls (Fig 2, g, h). On the other hand,
mRNA levels for estrogen receptor 2 were undetectable
in samples from patients and controls.
DISCUSSION
This pilot study documented that serum estradiol levels
of the GSV part of the lower extremity were significantly
higher than those of the antecubital vein of the upper
extremity in men with GSV reflux 500 ms with varicose
veins (VM) as well as in healthy male controls (HM).
Interestingly, only in the presence of reflux (VM) are serum
levels of testosterone in GSV significantly higher than in the
arm. No difference between leg and arm was seen in andro-
stenedione levels and blood count parameters in the VM
and HM groups. Regarding the mean age of the VM and
HM groups, however, the VM patients were significantly
older than the HM group. The decline with age in serum
levels of hormones in men is known as partial androgen
deficiency in aging men.13 Our study also showed a discrete
decline in the HM group of the serum level of testosterone
with age in the arm and leg blood sample. Interestingly, in
the VM group, the arm and leg serum level of testosterone
remained age-independent (arm) or increased (leg), but
the role of this finding remains to be determined.
The process of varicose vein formation is probably
Fig 2. Enzymes involved in steroid metabolism were
controls: (a) 5	-reductase type 1, (b) 5	-reductase type
(HSD), (e) aromatase, and (f) 3-HSD type 2 expressio
at 100%, and messenger RNA (mRNA) gene expressio
percentage of the change from control. Hormone recep
patient samples compared with control. Expression of (g
was down-regulated in patient samples compared with co
samples was set at 100%, andmRNA gene expression of th
of the change from control.multifactorial and a complex process.14 An abnormal dis-tensibility of the venous wall has been proposed as the
origin of the disease. Varicose veins can be formed in any
segment of the limb. In particular, tributaries that connect
to axial veins can be varicose without any reflux in the
communicating vein. Risk factors found to be associated
with varicose veins include genetic factors facilitated by
environmental influences such as prolonged hydrostatic
pressure, pregnancy, age, greater height, and obesity.15,16
The occurrence of venous stasis during pregnancy and the
presence of sex steroid hormone receptors in saphenous
veins have suggested a sex hormone dependency of the
venous pathology.17 Sex hormones may contribute to this
phenomenon, because high serum levels of estradiol are
associated with increased venous distensibility and varicose
veins in menopausal women.4 In these studies, however,
blood was always taken from the arm veins under the
assumption that the level of sex hormones should be similar
in all peripheral vessels.
The importance of hormones and their metabolism for
the cardiovascular system in men has been elucidated quite
recently.18,19 Sex hormone receptors are found in both
varicose and healthy GSVs.20-22 Interestingly, low levels of
estrogen receptors were found in the varicose part of the
saphenous veins,23 which is in line with our own data
presented here. In target tissues, sex hormones exert their
effects through receptor proteins located in the nuclear
compartment of the cells24 and through cell membrane
n-regulated in samples from patients compared with
c) 17, 20 lyase, (d) 17-hydroxysteroid dehydrogenase
ne expression of the enzymes of control samples was set
the enzymes in patient samples was calculated as the
nvolved in steroid metabolism were down-regulated in
rogen receptor and (h) estrogen receptor (ESR) type 1
ls. Gene expression of the hormone receptors of control
ymes in patient samples was calculated as the percentagedow
2, (
n. Ge
n of
tors i
) and
ntro
e enzaction.25 Steroids have been shown to elicit cellular re-
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entering the cell. In particular, a rapid rise of intracellular
calcium concentration is observed in a variety of cell
types.26 Expression of androgen and estrogen receptor type
1 in saphenous veins was demonstrated in the present
study. Interestingly, the expression of both receptors was
lower in GSVs with reflux than in healthy ones. This is likely
to be of relevance for vascular effects of estrogen/testosterone
or susceptibility to disease, or both. However, the low level
of androgen and estrogen receptor type 1 and the absence
of estrogen receptor type 2 in most GSVs with reflux could
be either specific to the saphenous vein or due to a loss of
the receptors during the degenerative process at the pres-
ence of GSV reflux and symptomatic varicose veins. Then
again, GSVs used for coronary artery bypass grafting have
also some degree of pre-existing fibrotic changes in the
wall.27
The vascular endothelium has a crucial role in the
regulation of vascular homeostasis by controlling coagula-
tion, inflammatory responses, and vascular tone. Estradiol
may influence the vascular reactivity28 due to increased
nitric oxide (NO) expression and increase NO production
and subsequent vasorelaxation. Estrogen also has the ca-
pacity to suppress the endothelial adhesion of monocytes.29
Further, oral estrogen increases the risk of venous throm-
boembolism in postmenopausal women.30 Whether the
physiologic role of estradiol is similar in veins and arteries
and whether it is similar in men and women remains un-
known.
The serum level of testosterone was significantly differ-
ent between the veins in the arm compared with the level in
the leg in presence of varicose veins with reflux in the GSV.
The normal range of testosterone is 9.9 to 27.8 nmol/L. In
the VM group with a GSV reflux 500 ms, the level of
testosterone showed a mean of 44.85 nmol/L (range,
8.82-225.1 nmol/L). Testosterone, the main androgen in
the circulation, is mainly protein-bound either to the sex
hormone-binding globulin or to albumin.31 We could
exclude, however, that differences in sex hormone-binding
globulin serum levels account for the differences in testos-
terone levels between arm and leg in the VM group (data
not shown).
At present, we can only speculate on the mechanisms
responsible for the differences in sex hormone levels in the
venous blood of arms and legs. In men, the predominant
sites of secretion for androgens are the interstitial Leydig
cells of the testis32 and, only to a smaller extent, the adrenal
glands. Aromatase, an enzymatic complex localized in the
endoplasmic reticulum of numerous tissues, ensures the
conversion of androgens into estrogens.33 One possible
explanation for the observed differences could be a reflux
from gonadal veins or adrenal veins, especially with stand-
ing position, into the main saphenous veins. Perhaps trib-
utary veins could be investigated in formalin-fixed bodies.
At the moment, however, we cannot provide any evidence.
On the other hand, sex steroids, in addition to their go-
nadal source, can also be synthesized by peripheral tis-
sues.34 We thus tested whether a synthesis of sex steroidhormones can also occur in GSVs with reflux. Our data
show that at least at the mRNA level, the saphenous vein
expresses key enzymes involved in steroid synthesis. Inter-
estingly, these enzymes are down-regulated in GSVs with
reflux and varicose veins compared with the healthy GSVs,
a finding that suggests a negative feedback regulation.
Indeed, high source levels may lead to reduced expression
of the metabolizing enzymes to avoid the production of
high levels of active metabolites. As a consequence, venous
blood flow may be directly modulated by steroid hor-
mones.
Limitations of the present study include the small study
sample with only white men, which may not be represen-
tative of all men who develop a reflux of the GSV and
varicose veins. Especially in the VM group, only two were
fromC2 and the rest were frommore advanced C classes, so
that reflux of GSV with varicose veins may not be the only
thing in the comparison. For further investigations, pa-
tients should be selected in by C grouping, such as only C2,
C3 or only C5, C6 and compared with a control group
without any signs of venous reflux or signs of chronic
venous disorders.
The interpretability of these results may be limited by the
complex interrelations of the sex hormones with other hormone
systems, with common chronic diseases of aging such as cardio-
vascular disease, diabetes, hyperlipidemia, and with associated
conditions and behavior such as obesity.35
CONCLUSIONS
The vasculature is controlled by a plethora of growth
and inhibitory modulators;36 therefore, our findings may
simply be an epiphenomenon in such a complex system.On
the other hand, our observation of different serum concen-
trations of important sex steroid hormones (estradiol and
testosterone) in patients with GSV reflux and symptomatic
varicose veins and healthy arm veins may have implications
for the pathogenesis of varicose veins in men. Certainly, the
regulation of sex steroid serum levels in the varicose and
healthy segments of peripheral veins desires further clinical
and laboratory studies.
Authors MK, EM participated equally and share first
authorship. Authors CZ and JS share senior authorship.
We are indebted to all patients who participated in this
study and to the staff of the Department of Cardiac Sur-
gery, Heart Center, University of Leipzig for their support.
We thank Bettina Hentschel, Institute of Medical Infor-
matics, Statistics and Epidemiology, Leipzig University
Center, for her valuable assistance in supervising the study
design and helping analyzing the data.
AUTHOR CONTRIBUTIONS
Conception and design: MK, EM, TW
Analysis and interpretation: MK, EM, CZ
Data collection: MK, EM, JG, UA
Writing the article: MK, EM
Critical revision of the article: MK, EM, JG, TW, CZ, UA, JS
Final approval of the article: MK, JG, CZ, JS
JOURNAL OF VASCULAR SURGERY
March 2010646 LabropoulosStatistical analysis: MK, EM, JG
Obtained funding: JS, CZ
Overall responsibility: MK
REFERENCES
1. Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier
F, et al. Primary chronic venous disorders. J Vasc Surg. 2007;46:54S-
67S.
2. Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkers FGR. What
are the symptoms of varicose veins? Edinburgh vein study cross sectional
population survey. Br Med J 1999;319:353-6.
3. Rabe E, Pannier-Fischer F, Bromen K, Schuldt K, Stang A, Poncar CH,
et al. Bonner Studie der Deutschen Gesellschaft für Phlebologie. Epi-
demiologische Untersuchung zur Frage der Häufigkeit und Ausprä-
gung von chorischen Venenkrankheiten in der städtischen und ländli-
chen Wohnbevölkerung. Phlebologie 2003;32:1-14.
4. Maurins U, Hoffmann BH, Lösch C, Jöckel KH, Rabe E, Pannier F.
Distribution and prevalence of reflux in the superficial and deep venous
system in the general population—results from the Bonn Vein Study,
Germany. J Vasc Surg 2008;48:680-7.
5. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiol-
ogy of varicose veins: the Framingham Study. Am J Prev Med 1988;4:
96-101.
6. Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau
MR, Eklof B. Chronic venous disease. N Engl JMed 2006;355:488-98.
7. Ciardullo AV, Panico S, Bellati C, Rubba P, Rinaldi S, Iannnuzzi A, et
al. High endogenous estradiol is associated with increased venous
distensibility and clinical evidence of varicose veins in menopausal
women. J Vasc Surg 2000;32:544-9.
8. Bromen K, Pannier-Fischer F, Stang A, Rabe E, Bock E, Jockel KH.
Should sex specific differences in venous diseases be explained by
pregnancies and hormone intake? Gesundheitswesen 2004;66:170-4.
9. Kendler M, Blendinger CH, Haas E. Elevated serum estradiol/testosterone
ratio in men with primary varicose compared with a healthy control
group. Angiology 2009;60:283-9.
10. Howell RG, Burton JL. Decreased fertility in men with venous stasis of
the legs. Lancet 1982;18:630-1.
11. Oswald M, Heintz C, Wohlaib U. How to prove incompetence of the
ovarian vein as a source of varicogenesis by testing the hormone content
of the varicose veins of the leg. Phlebolymphology. Special issue for
European Congress of UIP, Bremen, 1999.
12. Labropoulos N, Tiongson J, Pryor L, Tassiopoulos AK, Kang SS, Ashraf
Mansour M, et al. Definition of venous reflux in lower-extremity veins.
J Vasc Surg 2003;38:793-8.
13. Frajese GV, DeMartinoMU, Calcagni E, Pastore R, CaprioM, Bultrini
A, et al. The epidemiology of partialandrogen deficiency in aging men
(PADAM). J Endocrinol Invest 2005;28(suppl):3-7.
14. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve
dysfunction and wall dilation. Phlebology 2008;23:85-98.
15. Vanhoutte PM, Corcaud S, de Montrion C. Venous disease: from
pathophysiology to quality of life. Angiology 1997;48:559-67.
16. Kisch D, Dienes HP, Küchle R, Duschner H, Wahl H, Böttger T, et al.
Changes in the extracellular matrix, of the vein wall: the cause of
primary varicosis? Vasa 2000;29:173-7.
17. Bergqvist A, Bergqvist D, Fernö M. Estrogen and progesterone recep-
tors in vessel walls. Act Obstet Gynecol Scand 1993;72:10-5.
strated. Until the current study, few reports suggested a possible18. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW,
Grobbee DE. Endogenous hormones and carotid atherosclerosis in
elderly men. Am J Epidemiol 2003;157:25-31.
19. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer
KS. Men with coronary artery disease have lower levels of androgens
than men with normal coronary angiograms. Eur Heart J 2000;21:
890-4.
20. Krasinski Z,Dzieciuschowicz L, KotwickaM,GabrielM, Szcesniak-Chmi-
elecka A, Krasinska B, et al. Sex hormone receptros in varicose veins of
women with premenstrual syndrome. Phlebologie 2008;37:68-72.
21. Schmidt JB, Seidl K, Spona J. [Hormone interactions in varicose
veins-receptor analysis and hormone level] German. Vasa 1986;15:
224-7.
22. Mashiah A, Berman V, Thole HH, Rose SS, Pasik S, Schwarz H, et al.
Estrogen and progesterone receptors in normal and varicose saphenous
veins. Cardiovasc Surg 1999;7:327-31.
23. Perrot-Applanat M, Cohen-Solal K, Milgrom E, Finet M. Progesterone
receptor expression in human saphenous veins. Circulation 1995;92:
2975-83.
24. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and
lipid physiology: opening the X-files. Science 2001;294:1866-70.
25. GöttlicherM,Heck S,Herrlich P. Transcriptional cross-talk, the second
mode of steroid hormone receptor action. J Mol Med 1998;76:480-9.
26. Benten WP, Stephan C, Lieberherr M, Wunderlich F. Estradiol signaling
via sequestrable surface receptors, Endocrinology 2001;142:1669-77.
27. Giannoukas AD, Labropoulos N, Stavridis G, Bailey D, Glenville B,
Nicolaides AN. Pre-bypass quality assessment of the long saphenous
vein wall with ultrasound and histology. Eur J Vasc Endovasc Surg
1997;14:37-40.
28. Sudhir K, Komesaroff PA. Clinical review 110: cardiovascular actions of
estrogens in men. J Clin Endocrinol Metab 1999;84:3411-5.
29. Villar IC, Hobbs AJ, Ahluwalia A. Sex differences in vascular function:
implication of endothelium-derived hyperpolarizing factor. J Endocri-
nol 2008;197:447-62.
30. CanonicoM, Plu-BureauG, LoweGD, Scarabin PY.Hormone replace-
ment therapy and risk of venous thromboembolism in postmenopausal
women: systematic review and meta-analysis. BMJ 2008;336:1227-31.
31. Schreiber G, Ziemer M. The aging male—diagnosis and therapy of
late-onset hypogonadism. J Dtsch Dermatol Ges 2008;6:273-9.
32. Oettel M. Testosterone metabolism, dose-response relationships and
receptor polymorphisms: selected pharmacological/toxicological con-
siderations on benefits versus risks of testosterone therapy in men.
Aging Male 2003;6:230-56.
33. Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual
hormones in human skin. Horm Metab Res 2007;39:85-95.
34. Luu-The V, Bélanger A, Labrie F. Androgen biosynthetic pathways in
the human prostate. Best Pract Res Clin Endocrinol Metab 2008;22:
207-21.
35. Lamberts SWJ, van den Beld AW, van der Lely AJ. The endocrinology
of aging. Science 1997;278:419-24.
36. Folkman J. Clinical applications of research on angiogenesis. Seminars
in medicine of the Beth Israel Hospital, Boston, MA. N Engl J Med
1995;333:1757-63.Submitted May 20, 2009; accepted Jul 18, 2009.INVITED COMMENTARYNicos Labropoulos, MD, Stony Brook, NY
Sexual steroid hormones are known to influence the endothe-
lial function of blood vessels. Several studies have shown an asso-
ciation between increased levels of estradiol and varicose veins in
women. Also, the effect of pregnancy in the diameter of the veins
and the development of reflux and varicose veins has been demon-association between sexual steroid hormones and varicose veins in
males. The important finding in this report is that estradiol and
testosterone serum levels were higher in refluxing veins of the
lower extremities when compared to those from the arm veins of
the same patients. It is also interesting that the serum levels of
estradiol and testosterone were significantly higher in lower ex-
